About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Chordia Therapeutics Inc.(190A) Summary

190A
TSE Growth
Chordia Therapeutics Inc.
315
JPY
+8
(+2.61%)
Dec 23, 10:42 am JST
2.01
USD
Dec 22, 8:42 pm EST
Result
PTS
outside of trading hours
317
Dec 23, 10:40 am JST
Summary Chart Historical News Financial Result
PER
PBR
5.17
Yield
ー%
Margin Trading Ratio
531.43
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
312 JPY 1.99 USD
Previous Close Dec 20
307 JPY 1.95 USD
High Dec 23, 9:29 am
328 JPY 2.09 USD
Low Dec 23, 9:06 am
303 JPY 1.93 USD
Volume
6,266,200
Trading Value
1.98B JPY 0.01B USD
VWAP
316.64 JPY 2.02 USD
Minimum Trading Value
31,500 JPY 201 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
3,509
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
5,951
1-Year High Jul 26, 2024
40,334
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 6,000 6,759,700 1126.62
Dec 6, 2024 8,000 6,774,800 846.85
Nov 29, 2024 5,500 7,654,200 1391.67
Nov 22, 2024 10,500 5,580,000 531.43
Nov 15, 2024 0 5,051,900
Company Profile
Chordia Therapeutics Inc. engages in the development of cancer therapeutics targeting RNA regulation stress.